Doctor Who Sold $12 Billion Drug Firm Eyes Biotech Property
(Bloomberg) -- A deal-making cancer doctor who sold his pharmaceutical company for almost $12 billion is launching a real estate venture to bolster the growth ...
Updated: 07/16/2019 11:58A
2 Incredibly Cheap Biotech Stocks to Buy Now
Despite the political headwinds over prescription drug prices in the United States, the biotech industry has still managed to post some rather respectable gains ...
Updated: 07/15/2019 10:17A
5 Best Biotech Stocks of 2019 So Far
We're past the halfway point in 2019. And there have been plenty of big winners among biotech stocks so far. Despite the threat of restrictive changes to the ...
Updated: 07/12/2019 07:15A